The U.S. Food and Drug Administration (FDA) has accepted a new drug application for gedatolisib for the treatment of patients ...

Gedatolisib's NDA for advanced breast cancer treatment has been accepted by the FDA, with a priority review and a PDUFA date ...

Speeding up drug discovery in the age of AI may come down to a concept that's comfortingly old-fashioned: Consulting a ...

Considering a switch from Windows to Linux? The good news is you don't have to give up your favorite Windows apps. Here's how to run them on Linux.

I tried four vibe-coding tools, including Cursor and Replit, with no coding background. Here's what worked (and what didn't).

The FDA commissioner's effort to shorten the review of drugs favored by the Trump administration is causing alarm across the ...

Schrödinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic ...

The newly launched program builds on previously published, peer-reviewed clinical research ( link to full publication) demonstrating that surface acoustic wave micro-vibration technology applied to ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

Novo Nordisk A/S (NYSE: NVO) on Thursday submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for once-weekly CagriSema. The application covers CagriSema for use with ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — A new program ...